QLY Biotech Group Corp.
LQLY
$1.00
-$0.06-5.66%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 4.00K | 4.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 4.00K | 4.00K |
| Cost of Revenue | -- | -- | -- | 1.40K | 1.40K |
| Gross Profit | -- | -- | -- | 2.60K | 2.60K |
| SG&A Expenses | 28.90K | 19.10K | 14.10K | 11.30K | 9.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.90K | 19.10K | 14.10K | 12.70K | 11.20K |
| Operating Income | -28.90K | -19.10K | -14.10K | -8.70K | -7.20K |
| Income Before Tax | -28.90K | -19.10K | -14.10K | -8.70K | -7.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.90K | -19.10K | -14.10K | -8.70K | -7.20K |
| EBIT | -28.90K | -19.10K | -14.10K | -8.70K | -7.20K |
| EBITDA | -28.80K | -18.50K | -13.20K | -7.80K | -6.30K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 15.58M | 15.58M | 15.58M | 15.58M | 15.58M |
| Average Diluted Shares Outstanding | 15.58M | 15.58M | 15.58M | 15.58M | 15.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |